Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
PRX-005 in Alzheimer Disease: NCT07780383 Clinical Landscape Report 2026
16 September 2026
NCT07780383 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Finerenone in Acute Kidney Injury: NCT07775482 Clinical Landscape Report 2026
16 September 2026
NCT07775482 clinical landscape for Acute Kidney Injury: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dapagliflozin Propanediol/Metformin Hydrochloride in Diabetes Mellitus, Type 2: NCT07778719 Clinical Landscape Report 2026
16 September 2026
NCT07778719 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
RO-7568282 in Parkinson Disease: NCT07781644 Clinical Landscape Report 2026
16 September 2026
NCT07781644 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Enzalutamide in Prostatic Cancer: NCT07783282 Clinical Landscape Report 2026
16 September 2026
NCT07783282 clinical landscape for Prostatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Semaglutide (Novo Nordisk) in Obesity: NCT07779343 Clinical Landscape Report 2026
16 September 2026
NCT07779343 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tirzepatide in Non-Small Cell Lung Cancer: NCT07782359 Clinical Landscape Report 2026
16 September 2026
NCT07782359 clinical landscape for Non-Small Cell Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
VGT-309 in Pancreatic Ductal Adenocarcinoma: ACTRN12626001037392 Clinical Landscape Report 2026
16 September 2026
ACTRN12626001037392 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development wh…
9 min read
Mecobalamin in Kidney Failure, Chronic: NCT07781020 Clinical Landscape Report 2026
16 September 2026
NCT07781020 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
NXP-900 in ALK positive Lung Cancer: NCT07784959 Clinical Landscape Report 2026
16 September 2026
NCT07784959 clinical landscape for ALK positive Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Camrelizumab in Locally Advanced Esophageal Squamous Cell Carcinoma: NCT07787273 Clinical Landscape Report 2026
16 September 2026
NCT07787273 clinical landscape for Locally Advanced Esophageal Squamous Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and dev…
9 min read
Recombinant meningococcal group B vaccine (Sanroad Biological Products) in Hepatitis B: NCT07784452 Clinical Landscape Report 2026
16 September 2026
NCT07784452 clinical landscape for Hepatitis B: endpoints, sponsor, phase, geography, readouts, asset context and development white space.